Anti-Tat Polyclonal Antibody from ProteoGenix; catalogue ARO-A22357; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Tat Polyclonal Antibody
The Anti-Tat Polyclonal Antibody is a highly specific and sensitive tool for studying the role of the Tat protein in HIV infection. This antibody targets the Tat protein, a key regulator of HIV transcription and replication, making it an essential tool for understanding the molecular mechanisms of HIV pathogenesis.
The Tat protein is a small regulatory protein produced by the human immunodeficiency virus (HIV) that plays a critical role in the virus’s ability to replicate and cause disease. It is essential for the transcription of the viral genome and the production of new virus particles. The Anti-Tat Polyclonal Antibody specifically binds to the Tat protein, inhibiting its function and preventing HIV replication.
The Anti-Tat Polyclonal Antibody is a valuable tool for researchers studying HIV and its interaction with host cells. It can be used in a variety of applications, including Western blotting, immunoprecipitation, and immunofluorescence. This antibody is also suitable for use in flow cytometry and ELISA assays.
The Anti-Tat Polyclonal Antibody has been used in various research studies to investigate the role of the Tat protein in HIV pathogenesis. In one study, it was used to demonstrate the importance of Tat in viral replication and the development of AIDS-related dementia. In another study, it was used to show the potential of targeting Tat as a therapeutic strategy for HIV infection.
With its high specificity and sensitivity, the Anti-Tat Polyclonal Antibody is a crucial tool for understanding the molecular mechanisms of HIV and developing new treatments for this deadly virus. Order now and advance your research on HIV.
Research Target Keywords: HIV, Tat protein, pathogenesis, replication, molecular mechanisms, immunoprecipitation, immunofluorescence, flow cytometry, ELISA, AIDS-related dementia, therapeutic strategy, deadly virus.
ProteoGenix catalogue number ARO-A22357. For research use only.
Target: Protein Tat, Transactivating regulatory protein, tat; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Protein Tat, Transactivating regulatory protein, tat |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
